PubMed

Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects.

Chiang CK, Ho TI, Peng YS, Hsu SP, Pai MF, Yang SY, Hung KY, Wu KD.

Diabetes Care. 2007 Jan;30(1):3-7.PMID: 17192324 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.

Wong TY, Szeto CC, Chow KM, Leung CB, Lam CW, Li PK.

Am J Kidney Dis. 2005 Oct;46(4):713-9.PMID: 16183427 [PubMed - indexed for MEDLINE]Related articles

A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes.

Peters Harmel AL, Kendall DM, Buse JB, Boyle PJ, Marchetti A, Lau H.

Curr Med Res Opin. 2004;20(2):215-23.PMID: 15006017 [PubMed - indexed for MEDLINE]Related articles

[One-year follow-up in real clinical practice conditions of type 2 diabetic patients treated with rosiglitazone: the Avantage study]

Slama G, Eschwège E, Bernard MH, Grimaldi A, Oppert JM, Pouchain D, Bégaud B; pour le groupe des investigateurs de l'étude Avantage.

Ann Endocrinol (Paris). 2008 Feb;69(1):36-46. Epub 2008 Feb 20. French. PMID: 18243155 [PubMed - indexed for MEDLINE]Related articles

Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic Fatty liver disease.

Wang CH, Leung CH, Liu SC, Chung CH.

J Formos Med Assoc. 2006 Sep;105(9):743-52.PMID: 16959622 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.

Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT.

Am J Cardiol. 2006 Mar 1;97(5):646-50. Epub 2006 Jan 9.PMID: 16490430 [PubMed - indexed for MEDLINE]Related articles

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors.

Chiquette E, Ramirez G, Defronzo R.

Arch Intern Med. 2004 Oct 25;164(19):2097-104.PMID: 15505122 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.

Pfützner A, Schöndorf T, Seidel D, Winkler K, Matthaei S, Hamann A, Forst T.

Metabolism. 2006 Jan;55(1):20-5.PMID: 16324915 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.

Starner CI, Schafer JA, Heaton AH, Gleason PP.

J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31.PMID: 18693776 [PubMed - indexed for MEDLINE]Related articlesFree article

Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real-life experience from a tertiary hospital.

Hussein Z, Wentworth JM, Nankervis AJ, Proietto J, Colman PG.

Med J Aust. 2004 Nov 15;181(10):536-9.PMID: 15540964 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of rosiglitazone on serum liver biochemistries in diabetic patients with normal and elevated baseline liver enzymes.

Chalasani N, Teal E, Hall SD.

Am J Gastroenterol. 2005 Jun;100(6):1317-21.PMID: 15929763 [PubMed - indexed for MEDLINE]Related articles

Effects of rosiglitazone on plasma brain natriuretic peptide levels and myocardial performance index in patients with type 2 diabetes mellitus.

Türkmen Kemal Y, Güvener Demirag N, Yildirir A, Atar A, Dogruk Unal A, Biyiklioglu Z.

Acta Diabetol. 2007 Sep;44(3):149-56. Epub 2007 Aug 26.PMID: 17721754 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis.

Manley HJ, Allcock NM.

Pharmacotherapy. 2003 Jul;23(7):861-5.PMID: 12885099 [PubMed - indexed for MEDLINE]Related articles

[The effect of single nucleotide polymorphism SNP + 45 of the adiponectin gene on the rosiglitazone maleate response in patients with type 2 diabetes]

Zhang H, Jia WP, Hu C, Zhang R, Wang CR, Bao YQ, Lu JX, Xu J, Xiang KS.

Zhonghua Yi Xue Za Zhi. 2007 Sep 11;87(34):2390-3. Chinese. PMID: 18036314 [PubMed - indexed for MEDLINE]Related articles

Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes.

Yilmaz H, Gursoy A, Sahin M, Guvener Demirag N.

Acta Diabetol. 2007 Dec;44(4):187-92. Epub 2007 Aug 29.PMID: 17726570 [PubMed - indexed for MEDLINE]Related articles

Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus.

Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Liapis CD, Alevizos M.

Diabet Med. 2008 Mar;25(3):333-40.PMID: 18307460 [PubMed - indexed for MEDLINE]Related articles

Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.

Hollander P, Yu D, Chou HS.

Arch Intern Med. 2007 Jun 25;167(12):1284-90.PMID: 17592102 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.

Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA.

JAMA. 2007 Dec 12;298(22):2634-43.PMID: 18073359 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of dual PPAR alpha/gamma stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients.

Seber S, Ucak S, Basat O, Altuntas Y.

Diabetes Res Clin Pract. 2006 Jan;71(1):52-8. Epub 2005 Jul 11.PMID: 16009445 [PubMed - indexed for MEDLINE]Related articles